This site is intended for health professionals only

New study offers flu vaccine hope

teaser

A piece of the flu virus not affected by mutations could hold the key to a generic vaccine, scientists have claimed.

Researchers writing in the mBio journal said they had found a way of exploiting a vulnerability in the organism which had allowed them to develop a new treatment.

The team, from Mount Sinai School of Medicine in New York, focused their efforts on the hemagglutinin part of the virus, a mushroom-shaped structure which remains static during mutations.

Article continues below this sponsored advert
Featured Image
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
Advertisement

Scientists on the project found a way to get to the protected “neck” of the hemagglutinin, after which it was cut out and used to develop a vaccine.

Tests on mice showed the substance protected them from otherwise lethal doses of multiple strains of influenza.

Flu viruses change constantly, with a new pandemic emerging every few decades.

Copyright Press Association 2010
mBio






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x